According to the American Cancer Society, in 2021, there will be an estimated 41,000 new cases of cancer in Arizona and an estimated 15,580 deaths will result from this disease. For for every new cancer patient diagnosed there will be at least one new cancer caregiver and/or family to care for that patient.Continue reading
Author Archive: AZBio
AZBio and Verigility Host a Discussion on Building Resilient Teams as part of Global Entrepreneurship Week
The Arizona Bioindustry Association (AZBio) and Verigility hosted a discussion on Building Resilient Teams as part of Arizona’s Global Entrepreneurship Week celebration. Continue reading
UArizona Alumnus R. Ken Coit Commits $50M to Advance College of Pharmacy
The transformative gift establishes endowed positions and scholarships and expands the college’s History of Pharmacy Museum. The college will be renamed in recognition of R. Ken Coit’s support.Continue reading
Mayo Clinic poised to biomanufacture a new era of biotherapeutics
Mayo Clinic has launched a new biomanufacturing strategy that seeks to develop next-generation biotherapeutics that go beyond standard pharmaceuticals and deliver new cures for rare and complex conditions.
Study Shows Vaccine Protects Dogs Against Valley Fever
A team led by researchers at the University of Arizona Valley Fever Center for Excellence successfully tested a Valley fever vaccine for dogs, with two doses providing high levels of protection against the fungal disease.Continue reading
Researchers Develop Tools to Listen, Talk to Plants with $25M from NSF
Through a newly established NSF Science and Technology Center, University of Arizona researchers will use digital tools to communicate with plants and develop new crops to support sustainable agriculture.Continue reading
Humabiologics partners with Funakoshi to distribute human biomaterials in Japan
Humabiologics products are now available to researchers in Japan for use in regenerative medicine translational research, cell therapy, bioprinting, tissue & disease modeling, and drug screening applications.Continue reading
FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Children 5 through 11 Years of Age
FDA Press Release: October 29, 2021 – Today, the U.S. Food and Drug Administration authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 to include children 5 through 11 years of age. The authorization was based on the FDA’s thorough and transparent evaluation of the data that included input from independent advisory committee experts who overwhelmingly voted in favor of making the vaccine available to children in this age group.Continue reading
UArizona Health Sciences Researchers Weaponizing Copper as Potential Antibiotic
Researchers identified a compound that acts as a Trojan horse for copper, effectively killing pathogens that cause some upper respiratory infections.Continue reading
leanRAQA releases new Business Market Assessment Tool for Life Science Innovators
The Business Market Assessment tool to helps you understand the initial investment and recurring regulatory compliance costs you’ll face. The guide walks you through the revenue vs cost modeling calculations to help you judge the market viability of your product and see if a specific market makes sense.